z-logo
open-access-imgOpen Access
USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling
Author(s) -
Lina Herhaus,
Mazin A. Al-Salihi,
Kevin S. Dingwell,
Timothy D. Cummins,
Lize Wasmus,
J. Vogt,
Richard Ewan,
David L. Bruce,
Thomas Macartney,
Simone Weidlich,
James C. Smith,
Gopal P. Sapkota
Publication year - 2014
Publication title -
open biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.078
H-Index - 53
ISSN - 2046-2441
DOI - 10.1098/rsob.140065
Subject(s) - biology , bone morphogenetic protein , microbiology and biotechnology , bmpr2 , signalling , bone morphogenetic protein 4 , hedgehog signaling pathway , signal transduction , bone morphogenetic protein receptor , bone morphogenetic protein 2 , genetics , in vitro , gene
Protein kinase ALK3/BMPR1A mediates bone morphogenetic protein (BMP) signalling through phosphorylation and activation of SMADs 1/5/8. SMAD6, a transcriptional target of BMP, negatively regulates the BMP pathway by recruiting E3 ubiquitin ligases and targeting ALK3 for ubiquitin-mediated degradation. Here, we identify a deubiquitylating enzyme USP15 as an interactor of SMAD6 and ALK3. We show that USP15 enhances BMP-induced phosphorylation of SMAD1 by interacting with and deubiquitylating ALK3. RNAi -mediated depletion of USP15 increases ALK3 K48-linked polyubiquitylation, and reduces both BMP-induced SMAD1 phosphorylation and transcription of BMP target genes. We also show that loss of USP15 expression from mouse myoblast cells inhibits BMP-induced osteoblast differentiation. Furthermore, USP15 modulates BMP-induced phosphorylation of SMAD1 and transcription during Xenopus embryogenesis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom